Merck & Co., Inc. (MRK)
106.52
+1.48
(+1.41%)
USD |
NYSE |
Dec 24, 12:59
106.26
-0.26
(-0.25%)
After-Hours: 13:59
Merck Market Cap: 264.40B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 179.79B |
| Biogen, Inc. | 25.89B |
| Regeneron Pharmaceuticals, Inc. | 82.41B |
| Cidara Therapeutics, Inc. | 6.946B |
| Moderna, Inc. | 12.79B |
Market Cap Related Metrics
| PE Ratio | 14.09 |
| PS Ratio | 4.201 |
| PEG Ratio | 0.2416 |
| Price to Book Value | 5.099 |
| Price to Free Cash Flow | 20.57 |
| Price | 106.52 |
| Earnings Yield | 7.10% |
| PEGY Ratio | 0.2293 |
| Operating PE Ratio | 10.56 |
| Normalized PE Ratio | 12.47 |